Our results showed that the expression levels of miR-154-5p and RSF1 were up-regulated in recurrent bladder cancer while RUNX2 was down-regulated, and the differences were insignificant (Figure 5A). The gene discussed is RUNX2; the disease is urinary bladder carcinoma.